Ekso Bionics Holdings, Inc.

EKSO

US2826444000

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-06 pm EST			5-day change	1st Jan Change
10.41 ^USD	+11.22%		+19.66%	+20.49%

Jan. 21	Ekso Bionics Holdings, Inc. announced that it has received $5.852 million in funding	CI
Jan. 19	Ekso Bionics Holdings, Inc. announced that it expects to receive $5.852 million in funding	CI

Top Premarket Decliners

Published on 12/31/2025 at 08:09 am EST

MT Newswires

Latest news about Ekso Bionics Holdings, Inc.

Jan. 21	Ekso Bionics Holdings, Inc. announced that it has received $5.852 million in funding	CI
Jan. 19	Ekso Bionics Holdings, Inc. announced that it expects to receive $5.852 million in funding	CI
Jan. 07	Applied Digital beats quarterly revenue estimates on AI data center demand, shares jump	RE
Jan. 02	North American Morning Briefing : Stock Futures Rise as 2026 Trading Year Begins -2-	DJ
Dec. 31	Equity Futures Edge Higher Premarket Wednesday After Better-Than-Expected Jobless Claims Report	MT
Dec. 31	Top Premarket Decliners	MT
Dec. 30	US Equity Indexes Lower After FOMC Minutes Reveal Support for Keeping Rates Unchanged	MT
Dec. 30	US Equity Markets Fall After FOMC Minutes Show Narrow Support for Rate Cut	MT
Dec. 30	Financials, Consumer Discretionary Push US Equity Indexes Lower	MT
Dec. 30	Top Midday Gainers	MT
Dec. 30	Sector Update: Tech Stocks Mixed Pre-Bell Tuesday	MT
Dec. 30	US Equity Futures Flat Pre-Bell as Holiday Doldrums Continue Ahead of Fed Notes Release	MT
Dec. 30	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Fed Meeting Minutes	MT
Dec. 30	Sector Update: Tech	MT
Dec. 30	Top Premarket Gainers	MT
Dec. 29	Applied Digital to spin out cloud business, proposes business combination with Ekso to launch Chronoscale	RE
Dec. 29	Applied Digital Sign Non-Binding Term Sheet to Merge Cloud Computing Business With EKSO Bionics	MT
Dec. 28	Applied Digital Cloud Corporation signed a letter of intent to acquire Ekso Bionics Holdings, Inc. in a reverse merger transaction.	CI
Dec. 04	Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's BalanceTutor Rehabilitation System	CI
Dec. 04	Ekso Bionics inks agreement to become the exclusive U.S. distributor of Meditouch's groundbreaking BalanceTutor rehabilitation system	RE
Nov. 24	Top Premarket Gainers	MT
25-10-29	Ekso Bionics announces $3.7 million registered direct offering of common stock priced at-the-market under Nasdaq rules	RE
25-10-28	Ekso Bionics reports third quarter 2025 financial results	RE
25-10-28	Ekso Bionics' Q3 revenue up on high margin sales	RE
25-10-28	Ekso Bionics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Chart Ekso Bionics Holdings, Inc.

Duration

Period

EKSO: Dynamic Chart

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

Feb. 18 - Q4 2025 Earnings Release (Projected)

More about the company